« Previous
Next »
Cardiovascular Pathology
Volume 19, Issue 4
, Pages 207-217
, July 2010
Prevention of sudden cardiac death in the young and in athletes: dream or reality?
References
- . Cardiovascular causes of sudden death. In: Silver MD, Gotlieb AI, Schoen FJ editor. Cardiovascular pathology. 3rd ed.. Philadelphia: Churchill Livingstone; 2001;p. 326–374
- . Essay: sudden death in young athletes. Lancet. 2005;366:547–548
- . Does sports activity enhance the risk of sudden death in adolescents and young adults?. J Am Coll Cardiol. 2003;42:1959–1963
- . Sudden death due to cardiac arrhythmias. N Engl J Med. 2001;345:1473–1482
- Congenital heart disease and sudden death in the young. Hum Pathol. 1995;26:1065–1072
- An echocardiographic survey of primary school children for bicuspid aortic valve. Am J Cardiol. 2004;93:661–663
- . Aortic root dilatation in young men with normally functioning bicuspid aortic valves. Heart. 1999;82:19–22
- Aortic elasticity and size in bicuspid aortic valve syndrome. Eur Heart J. 2008;29:472–479
- . Sudden death in the young: is coronary thrombosis the major precipitating factor?. Circulation. 1994;90:2315–2323
- . The relationship between growth of atherosclerotic plaques, variant angina and sudden death. Int J Cardiol. 1990;26:361–367
- . Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. Am J Med. 1990;89:588–596
- Anomalous origin of coronary arteries and risk of sudden death: a study based on an autopsy population of congenital heart disease. Hum Pathol. 1998;29:689–695
- . Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol. 2000;35:1493–1501
- . Non-atherosclerotic coronary artery disease and sudden death in the young. Br Heart J. 1992;68:601–607
- . Anomalous origin of the left circumflex coronary artery from the right aortic sinus of Valsalva and sudden death. Cardiovasc Pathol. 1994;3:269–271
- . Myocardial infarction in a patient with hypertrophic cardiomyopathy. N Engl J Med. 2000;342:593–594
- . Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988;318:129–133
- . Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings. Cardiovasc Res. 2001;50:290–300
- . Arrhythmogenic right ventricular cardiomyopathy: dysplasia, dystrophy, or myocarditis?. Circulation. 1996;94:983–991
- . Arrhythmogenic right ventricular cardiomyopathy. An update. Cardiovasc Pathol. 2001;10:109–111
- . Arrhythmogenic RV cardiomyopathy/dysplasia: recent advances. Milano: Springer; 2007;
- Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med. 2008;358:152–161
- Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J. 1994;71:215–218
- . Naxos disease and Carvajal syndrome: cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy. Cardiovasc Pathol. 2004;13:185–194
- Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm. 2004;1:3–11
- Ultrastructural evidence of intercalated disc remodelling in arrhythmogenic right ventricular cardiomyopathy: an electron microscopy investigation on endomyocardial biopsies. Eur Heart J. 2006;27:1847–1854
- . Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2009;373:1289–1300
- Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet. 2002;71:1200–1212
- Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation. 2006;113:1171–1179
- Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2005;111:3042–3050
- Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria. Eur Heart J. 2008;29:2760–2771
- . Hypertrophic cardiomyopathy: pathologic evidence of ischemic damage in young sudden death victims. Hum Pathol. 2000;31:988–998
- . Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA. 1996;276:199–204
- . Sudden death in young athletes. N Engl J Med. 2003;349:1064–1075
- . Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med. 1998;339:364–369
- . February 18, 1982. Norme per la tutela sanitaria dell'attività sportiva agonistica [rules concerning the medical protection of athletic activity]. Gazzetta Ufficiale della Repubblica Italiana. 1982;63
- . Routine screening of all athletes prior to participation in competitive sports should be mandatory to prevent sudden cardiac death. Heart Rhythm. 2007;4:520–524
- . Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysiol. 2008;19:104–110
- Molecular diagnosis of myocarditis and dilated cardiomyopathy in children: clinicopathologic features and prognostic implications. Diagn Mol Pathol. 2002;11:212–221
- . Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects. Cardiovasc Res. 2003;60:11–25
- . Aortic root pathology and sudden death in youth: review of anatomical varieties. Appl Pathol. 1986;4:237–245
- . Sudden death in young people with apparently isolated mitral valve prolapse. G Ital Cardiol. 1997;27:1097–1105
- . Cardiac conduction system abnormalities as a possible cause of sudden death in young athletes. Human Pathology. 1983;14:704–709
- . Ventricular preexcitation in children and young adults: atrial myocarditis as a possible trigger of sudden death. Circulation. 2001;103:269–275
- . Enhanced A-V nodal conduction (Lown-Ganong-Levine syndrome) by congenitally hypoplastic A-V node. Eur Heart J. 1992;13:1579–1584
- . Recent advances in clinicohistopathologic correlates of sudden cardiac death. Am Heart J. 1981;102:478–484
- . Genetic aspects of cardiac conduction defects. Arch Mal Coeur Vaiss. 2003;96:1067–1073
- Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death. J Am Coll Cardiol. 1996;27:443–448
- . Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res. 2001;50:399–408
- . Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. J Am Coll Cardiol. 2007;49:240–246
- . Congenital long QT syndrome. Orphanet J Rare Dis. 2008;3:18
- Short QT syndrome: pharmacological treatment. J Am Coll Cardiol. 2004;43:1494–1499
- . Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 1992;20:1391–1396
- Ventricular fibrillation without apparent heart disease: description of six cases. Am Heart J. 1989;118:1203–1209
- Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation. 1997;96:2595–2600
- . Right bundle branch block, right precordial ST-segment elevation, and sudden death in young people. Circulation. 2001;103:710–717
- Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Gen. 2001;10:189–194
- Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation. 2001;103:196–200
- Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers. J Am Coll Cardiol. 2002;40:341–349
- . Molecular investigation of sudden death. G Ital Cardiol. 2007;8:752–759
- . Postmortem genetic testing for conventional autopsy-negative sudden unexplained death: an evaluation of different DNA extraction protocols and the feasibility of mutational analysis from archival paraffin-embedded heart tissue. Am J Clin Pathol. 2008;129:391–397
- Association for European Cardiovascular Pathology. Guidelines for autopsy investigation of sudden cardiac death. Virchows Arch. 2008;452:11–18
- Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA. 2007;298:405–412
- Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD. Herz. 2005;30:91–101
- Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2003;108:3084–3091
- Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy. Heart. 2007;93:708–710
- . Risk stratification and antiarrhythmic drug therapy. In: Marcus FI, Nava A, Thiene G editor. Arrhythmogenic RV cardiomyopathy/dysplasia: recent advances. Milano: Springer; 2007;p. 169–178
- Cardiovascular preparticipation screening of competitive athletes: a statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation. 1996;94:850–856
- . Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA. 2006;296:1593–1601
- Recommendations for competitive sports participation in athletes with cardiovascular disease. Eur Heart J. 2005;26:1422–1445
- Cardiovascular preparticipation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26:516–524
- . Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies. Circulation. 2006;113:1634–1637
This study was supported by the Registry for Cardiocerebrovascular Pathology, Veneto Region, Venice; Ministry of Health, Rome; and Fondazione Cariparo, Padova e Rovigo, Italy.
PII: S1054-8807(09)00028-3
doi: 10.1016/j.carpath.2009.04.001
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
Cardiovascular Pathology
Volume 19, Issue 4
, Pages 207-217
, July 2010
